Riskpilot← Back to searchSign inGet full accessInjeq Oyj
OYJBankruptY-tunnus 2367283-8Biokatu 8Manufacture of irradiation, electromedical and electrotherapeutic equipment · NACE 2660Est. 2010— employees
Revenue 2022
EUR 76K
+651% vs 2021
EBITDA margin
-2492.0%
-16% vs 2021
Equity ratio
38.9%
Financial strength
Net profit 2022
EUR -2,4M
-18% vs 2021
| Revenue | EUR 76K | +651% |
| EBITDA | EUR -1,9M | -16% |
| Net profit | EUR -2,4M | -18% |
| Total assets | EUR 4M | +16% |
| Equity | EUR 1,6M | +63% |
| Employees | — | — |
Legal name
Injeq Oyj
Y-tunnus number
2367283-8
Legal form
Julkinen osakeyhtiö
NACE code
2660 · Manufacture of irradiation, electromedical and electrotherapeutic equipment
Founded
27. lokakuuta 2010
Share capital
EUR 80 000
Employees
—
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on lääketieteellisen teknologian kehittäminen, valmistaminen ja myynti. Yhtiön toimialana on myös osakkeiden, osuuksien, kiinteistöjen ja maa-alueiden hallinta, omistaminen, ostaminen, myyminen ja vuokraaminen. Yhtiö voi tehdä myös konsultointia.
Address
Biokatu 8
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 10 | 76 |
| Staff expenses | −610 | −306 | −398 | −902 | −1 174 |
| EBITDA | −454 | −521 | −853 | −1 636 | −1 889 |
| Depreciation & amort. | −16 | −343 | −383 | −381 | −379 |
| EBIT | −470 | −865 | −1 237 | −2 016 | −2 268 |
| Net financials | −18 | −47 | −53 | −12 | −126 |
| Profit before tax | −487 | −911 | −1 290 | −2 028 | −2 394 |
| Tax | −0 | 6 | −0 | −0 | −0 |
| Net profit | −487 | −917 | −1 290 | −2 028 | −2 394 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 3 021 | 4 219 | 5 251 | 3 481 | 4 023 |
| Equity | 1 474 | 2 249 | 2 987 | 958 | 1 564 |
| Long-term debt | 1 414 | 1 749 | 1 893 | 2 132 | 1 919 |
| Short-term debt | 133 | 221 | 372 | 391 | 540 |
| Total debt | 1 547 | 1 970 | 2 265 | 2 523 | 2 459 |
EBITDA margin
-2492.0%
This company
15.8%
Market median
-15872% vs market
20182022
Equity ratio
38.9%
This company
38.2%
Market median
+2% vs market
20182022
Return on equity
-153.1%
This company
18.4%
Market median
-932% vs market
20182022
Net profit margin
-3157.7%
This company
8.1%
Market median
-39084% vs market
20182022
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20182022
Debt / equity
1.57×
This company
0.62×
Market median
-153% vs market
20182022
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SA Confidential Clerk | Confidential Clerk | 2021 |
TJ Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (5) | ||
TJ Confidential Clerk | Confidential Clerk | 2019 – 2021 |
MS Audit | Audit | 2018 – 2022 |
RM Chief Executive Officer | Chief Executive Officer | 2017 – 2019 |
KI Chief Executive Officer | Chief Executive Officer | 2019 – 2022 |
HK Audit | Audit | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2018 | |
| Board of Directors | 2022 | |
| Board of Directors | 2018 | |
| Board of Directors | 2023 | |
| Chairperson | 2022 | |
| Former (7) | ||
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2021 – 2021 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2019 – 2021 | |
| Board of Directors | 2018 – 2021 | |
| Board of Directors | 2018 – 2022 | |
| Board of Directors | 2018 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Injeq Oyj also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Timo Jaakko Tapani Elomaa | Confidential Clerk | 0 companies |
| Satu Anna Maarit Sinisalo | Confidential Clerk | 0 companies |
| Mikko Sakari Laijoki | Audit | 0 companies |
| Rami Marko Rainer Lehtinen | Chief Executive Officer | 0 companies |
| Timo Juha Hänninen | Chief Executive Officer | 0 companies |
| Kari Ilari Antila | Chief Executive Officer | 0 companies |
| Hanna-Leena Keskinen | Audit | 0 companies |
| Tommi Mikael Majaus | Board of Directors | 0 companies |
| Tommi Antti Jussi Rasila | Board of Directors | 0 companies |
| Jari Aarne Kalevi Hyttinen | Board of Directors | 0 companies |
| Piritta Anniina Setälä | Board of Directors | 0 companies |
| Tommi Alpi Siikaniva | Board of Directors | 0 companies |
| Timur Juhana Kärki | Board of Directors | 0 companies |
| Kari-Pekka Sakari Tammela | Board of Directors | 0 companies |
| Tomi Juhani Numminen | Chairperson | 0 companies |
| Kari Olavi Jääskeläinen | Board of Directors | 0 companies |
| Jan Arno Brynolf Lindgren | Board of Directors | 0 companies |
| Riitta Marjaana Seppänen-Kaijansinkko | Board of Directors | 0 companies |
| Katja Eveliina Paassilta | Board of Directors | 0 companies |